Advertisement Spectrum Announces TCI America Distribution Agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
More info about Spectrum Chemical

Spectrum Announces TCI America Distribution Agreement

New Brunswick, NJ (PRWEB) April 16, 2012 — Spectrum Chemicals & Laboratory Products has become a premier US distributor for TCI America, an internationally recognized leader providing specialty chemicals for research and science. This agreement provides Spectrum access to one of the most comprehensive line of organics for R&D, biochemical, medicinal chemistry and general laboratory use and pushes Spectrum’s chemical offering to over 40,000 unique chemicals.

Spectrum’s major emphasis is on USP, NF, FCC, BP, EP, JP and ACS grade products, active pharmaceutical ingredients and controlled substances, excipients, dietary supplements, cosmetic ingredients, biochemicals, premade solutions, and a complete line of high-purity solvents for critical analytical applications.

"The addition of TCI America‘s line of research chemicals gives Spectrum access to the early research and scientific development processes in bioscience, glyco-chemistry, material science and organometallic reagents", says Mark Hurd, Spectrum’s General Manager.

He adds: "We are committed to increasing our profile across all stages of development through commercialization and TCI America products add to Spectrum‘s expanding product line."